AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HEALIUS LTD

0.455

-0.010-2.15%

Volume:3.91M

Turnover:1.77M

Market Cap:330.39M

PE:-0.80

High:0.465

Open:0.460

Low:0.445

Close:0.465

52wk High:1.070

52wk Low:0.300

Shares:726.13M

Float Shares:648.47M

Volume Ratio:0.50

T/O Rate:0.60%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.572

EPS(LYR):-0.572

ROE:-107.69%

ROA:1.18%

PB:1.93

PE(LYR):-0.80

Loading ...

Overview Company News Filings

Healius (ASX:HLS) Shares Face Value Trap Fears After Goodwill Hit

Simply Wall St.

Healius - Expects to Achieve T27 Target of Mid-to-High Single-Digit EBIT Margins by December 2028

THOMSON REUTERS

Healius FY Revenue Continuing Operations AUD 1,373.2 Million

THOMSON REUTERS

Healius Limited-FY26 Preliminary Final Report

THOMSON REUTERS

Healius Limited-Change of Share Registry Provider

THOMSON REUTERS

Australia's Proteomics International Soars on Distribution Deal with Healius

Healius Signs National Agreement Framework With Ramsay Health Care

MT Newswires Live

Healius - Enters National Agreement with Ramsay Health Care Subsidiaries

THOMSON REUTERS

Healius Ltd-healius Transitions Pathology Arrangements with Ramsay

THOMSON REUTERS

Healius - Pathology Arrangements Transition to National Framework from 1 July 2026

THOMSON REUTERS

Healius - New Ramsay Agreements Have Initial Terms of Two to Five Years

THOMSON REUTERS

Healius Says Macquarie Group Ceases to Be a Substantial Holder

MT Newswires Live

Healius Says Macquarie Becomes Substantial Holder

MT Newswires Live

Healius (ASX:HLS) Valuation After FY26 Guidance Cut And Rising Pathology Labour Cost Pressures

Simply Wall St.

Is Healius (ASX:HLS) Using an Agilex Sale to Quietly Recast Its Core Pathology Focus?

Simply Wall St.

Healius Faces More Pain Ahead in Pathology -- Market Talk

BUZZ-Australia's Healius at record low on inadequate funding, budget pressure woes

Healius Issues Fiscal Year 2026 Guidance Amid Pathology Pressures; Explores Sale of Agilex Biolabs; Shares Drop 21%

MT Newswires Live

Healius Hits All-Time Stock Low After Profit Warning -- Market Talk

Stock Track | Healius Ltd Plummets 10.31% Intraday Amid Funding Shortfall, Staff Cuts and Strategic Asset Review

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/HLS.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"HLS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"HLS.AU\",,,,,undefined,":{"symbol":"HLS.AU","market":"AU","secType":"STK","nameCN":"HEALIUS LTD","latestPrice":0.455,"timestamp":1787292720000,"preClose":0.465,"halted":0,"volume":3913224,"delay":0,"changeRate":-0.02150537634408604,"nameEN":"HEALIUS LTD","floatShares":648466707,"shares":726132843,"eps":-0.572,"marketStatus":"Market Closed","change":-0.01,"latestTime":"08-21 16:12:00 AEST","open":0.46,"high":0.465,"low":0.445,"amount":1771938,"amplitude":0.043011,"askPrice":0.46,"askSize":22222,"bidPrice":0.445,"bidSize":1125,"shortable":3,"etf":0,"ttmEps":-0.572,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.465,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.5028221574962518,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"HLS.AU","preClose":0.465,"auctionPrice":0.455,"auctionVolume":446738,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292599660}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"HLS.AU\",,,,,undefined,":{"symbol":"HLS.AU","floatShares":648466707,"roa":"1.18%","roe":"-107.69%","lyrEps":-0.572,"volumeRatio":0.5028221574962518,"shares":726132843,"dividePrice":0,"high":0.465,"amplitude":0.043011,"preClose":0.465,"low":0.445,"week52Low":0.3,"pbRate":"1.93","psRate":"0.24","week52High":1.07,"institutionHeld":0,"latestPrice":0.455,"committee":-0.903628,"eps":-0.572,"divideRate":0,"volume":3913224,"delay":0,"ttmEps":-0.572,"open":0.46,"prevYearClose":0.905,"prevWeekClose":0.4,"prevMonthClose":0.375,"prevQuarterClose":0.39,"fiveDayClose":0.4,"twentyDayClose":0.35,"sixtyDayClose":0.35,"dividendPayoutRate":0.3174518941928099,"dividendGrowthYears":1,"dividendGrowthRate":5.883333333333333,"fiveYearAvgDividendRate":0.13286655691160723},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HLS.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"HLS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787097600000,"name":null,"time":"","dateTimestamp":1787061600000,"actualEps":null},{"date":"2026-02-18","symbol":"HLS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771369200000,"name":null,"time":"","dateTimestamp":1771333200000,"actualEps":null},{"date":"2025-08-21","symbol":"HLS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-05-09","symbol":"HLS.AU","amount":0.413,"announcedDate":"2025-05-05","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-05-12","defaultRemindTime":1746748800000,"name":"HEALIUS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-23","payableDate":"2025-05-12","currency":"AUD","dateTimestamp":1746712800000,"payDate":"2025-05-23"},{"date":"2025-02-20","symbol":"HLS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740006000000,"name":null,"time":"","dateTimestamp":1739970000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HLS.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2021-03-25","recordDate":"2021-03-26","paymentDate":"2021-04-15","value":0.065,"currency":"AUD"},{"executeDate":"2021-09-13","recordDate":"2021-09-14","paymentDate":"2021-10-08","value":0.0675,"currency":"AUD"},{"executeDate":"2022-03-24","recordDate":"2022-03-25","paymentDate":"2022-04-05","value":0.1,"currency":"AUD"},{"executeDate":"2022-09-07","recordDate":"2022-09-08","paymentDate":"2022-09-21","value":0.06,"currency":"AUD"},{"executeDate":"2025-05-09","recordDate":"2025-05-12","paymentDate":"2025-05-23","value":0.413,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HLS.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660760464","title":"Healius (ASX:HLS) Shares Face Value Trap Fears After Goodwill Hit","url":"https://stock-news.laohu8.com/highlight/detail?id=2660760464","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660760464?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:38","pubTimestamp":1787164702,"startTime":"0","endTime":"0","summary":"Healius walked into these results trading at A$0.42 with flat performance over the past week and modest gains over the past three months. The stock carries a reputation as a deep value healthcare play. Today’s headline is not about a revenue story. It is about a large hit to equity value and rising leverage.\nThe company booked a sizeable goodwill impairment of A$332m and shifted from net cash of A$57.2m to net debt of A$32.8m. That combination sharpened the focus on the balance sheet and on...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-hls/healius-shares/news/healius-asxhls-shares-face-value-trap-fears-after-goodwill-h","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-hls/healius-shares/news/healius-asxhls-shares-face-value-trap-fears-after-goodwill-h","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HLS.AU","BK7501","BK7509","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660418658","title":"Healius - Expects to Achieve T27 Target of Mid-to-High Single-Digit EBIT Margins by December 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2660418658","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660418658?lang=en_us&edition=fundamental","pubTime":"2026-08-19 07:50","pubTimestamp":1787097003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F14J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HLS.AU","BK7501","BK7124","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660046490","title":"Healius FY Revenue Continuing Operations AUD 1,373.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660046490","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660046490?lang=en_us&edition=fundamental","pubTime":"2026-08-19 07:27","pubTimestamp":1787095626,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nPLX51VS89:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HLS.AU","BK7124","BK7501","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660900434","title":"Healius Limited-FY26 Preliminary Final Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2660900434","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660900434?lang=en_us&edition=fundamental","pubTime":"2026-08-19 07:26","pubTimestamp":1787095572,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nTUE93V3QQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7509","BK7501","BK7124","HLS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657350271","title":"Healius Limited-Change of Share Registry Provider","url":"https://stock-news.laohu8.com/highlight/detail?id=2657350271","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657350271?lang=en_us&edition=fundamental","pubTime":"2026-08-06 14:21","pubTimestamp":1785997317,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nTUEC1FVW0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","BK7501","HLS.AU","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653782201","title":"Australia's Proteomics International Soars on Distribution Deal with Healius","url":"https://stock-news.laohu8.com/highlight/detail?id=2653782201","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653782201?lang=en_us&edition=fundamental","pubTime":"2026-07-22 09:42","pubTimestamp":1784684561,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Proteomics International soars on distribution deal with Healius** Proteomics InternationalPIQ.AXrise as much as 50% to A$0.225, their highest level since May 6**Signsexclusive pathol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nL4N43O04Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7048","BK7501","BK7124","HLS.AU","PIQ.AU","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647346568","title":"Healius Signs National Agreement Framework With Ramsay Health Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2647346568","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647346568?lang=en_us&edition=fundamental","pubTime":"2026-06-29 05:45","pubTimestamp":1782683132,"startTime":"0","endTime":"0","summary":"Healius  entered into a national agreement framework with subsidiaries of Ramsay Health Care , effective Wednesday, according to an Australian bourse filing on June 26 after market hours.The framework replaces existing pathology leases and service arrangements with standardized agreements across 13 Ramsay-operated hospitals in New South Wales, Victoria, Queensland and Western Australia, per the filing.The new contracts, with initial terms of two to five years, are expected to generate around AU$45 million in annual revenue, subject to stable customer demand and economic conditions, the filing added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLV","LABU","BK4588","NHLD","BK4581","BK7501","XBI","BK4585","BK7509","BK7113","RHC.AU","HLS.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646345823","title":"Healius - Enters National Agreement with Ramsay Health Care Subsidiaries","url":"https://stock-news.laohu8.com/highlight/detail?id=2646345823","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646345823?lang=en_us&edition=fundamental","pubTime":"2026-06-26 15:09","pubTimestamp":1782457753,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nTUE60KQL5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7509","BK7501","BK7124","HLS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646334599","title":"Healius Ltd-healius Transitions Pathology Arrangements with Ramsay","url":"https://stock-news.laohu8.com/highlight/detail?id=2646334599","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646334599?lang=en_us&edition=fundamental","pubTime":"2026-06-26 15:09","pubTimestamp":1782457753,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nTUE60KQL5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HLS.AU","BK7124","BK7509","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646334548","title":"Healius - Pathology Arrangements Transition to National Framework from 1 July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2646334548","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646334548?lang=en_us&edition=fundamental","pubTime":"2026-06-26 15:09","pubTimestamp":1782457753,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nTUE60KQL5:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7509","RHC.AU","BK7501","BK7113","HLS.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646334547","title":"Healius - New Ramsay Agreements Have Initial Terms of Two to Five Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2646334547","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646334547?lang=en_us&edition=fundamental","pubTime":"2026-06-26 15:09","pubTimestamp":1782457753,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nTUE60KQL5:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RHC.AU","BK7124","HLS.AU","BK7509","BK7113","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637398188","title":"Healius Says Macquarie Group Ceases to Be a Substantial Holder","url":"https://stock-news.laohu8.com/highlight/detail?id=2637398188","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637398188?lang=en_us&edition=fundamental","pubTime":"2026-05-22 13:35","pubTimestamp":1779428151,"startTime":"0","endTime":"0","summary":"Healius (ASX:HLS) said Macquarie Group (ASX:MQG) and its controlled bodies corporate ceased to be substantial holders of the firm on Tuesday, according to a Friday Australian bourse filing.Its shares rose 2% in recent trading on Friday","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7124","BK7511","BK7509","MQG.AU","BK7501","BK7046","HLS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637780965","title":"Healius Says Macquarie Becomes Substantial Holder","url":"https://stock-news.laohu8.com/highlight/detail?id=2637780965","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637780965?lang=en_us&edition=fundamental","pubTime":"2026-05-21 12:58","pubTimestamp":1779339539,"startTime":"0","endTime":"0","summary":"Healius  said Macquarie Group  and its controlled bodies corporate acquired 5.06% voting power in the firm on Monday, becoming a substantial holder, according to a Thursday Australian bourse filing.Macquarie holds 36.7 million securities of the firm.Its shares rose over 2% in recent trading on Thursday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MQG.AU","BK7511","HLS.AU","BK7046","BK7501","BK7124","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636509740","title":"Healius (ASX:HLS) Valuation After FY26 Guidance Cut And Rising Pathology Labour Cost Pressures","url":"https://stock-news.laohu8.com/highlight/detail?id=2636509740","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636509740?lang=en_us&edition=fundamental","pubTime":"2026-05-17 17:39","pubTimestamp":1779010770,"startTime":"0","endTime":"0","summary":"Healius trading update puts labour costs and funding pressures in focus\nHealius (ASX:HLS) has updated its FY26 guidance and flagged higher pathology labour costs following Fair Work Commission rulings, alongside no new federal funding for pathology in the recent budget.\nThe company expects Group Underlying EBITDA of A$259 million to A$264 million and Group Underlying EBIT of A$30 million to A$35 million. It is also pointing to staff cuts and collection centre closures across its pathology...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-hls/healius-shares/news/healius-asxhls-valuation-after-fy26-guidance-cut-and-rising","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-hls/healius-shares/news/healius-asxhls-valuation-after-fy26-guidance-cut-and-rising","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7509","BK7124","HLS.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635170677","title":"Is Healius (ASX:HLS) Using an Agilex Sale to Quietly Recast Its Core Pathology Focus?","url":"https://stock-news.laohu8.com/highlight/detail?id=2635170677","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635170677?lang=en_us&edition=fundamental","pubTime":"2026-05-14 17:35","pubTimestamp":1778751307,"startTime":"0","endTime":"0","summary":"In May 2026, Healius Limited (ASX:HLS) announced it had appointed UBS Securities Australia to explore a potential sale of its standalone Agilex Biolabs unit after receiving unsolicited approaches from several credible parties, while confirming any transaction would not affect its core Pathology operations.\nThis potential divestment highlights management’s ongoing efforts to reshape the portfolio toward pathology-focused activities and crystalise value from non-core clinical trials assets...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-hls/healius-shares/news/is-healius-asxhls-using-an-agilex-sale-to-quietly-recast-its","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-hls/healius-shares/news/is-healius-asxhls-using-an-agilex-sale-to-quietly-recast-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7124","BK7509","HLS.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635750601","title":"Healius Faces More Pain Ahead in Pathology -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2635750601","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635750601?lang=en_us&edition=fundamental","pubTime":"2026-05-14 08:43","pubTimestamp":1778719380,"startTime":"0","endTime":"0","summary":"0043 GMT - There's more pain ahead for Healius in pathology services, suggests Jefferies. Healius now expects underlying Ebitda of A$259 million-A$264 million in FY 2026. It cited lower pathology volumes and higher costs as the reason for lower than previously expected profitability. Analyst David Stanton expects Healius's underlying Ebit will total some A$31 million in FY 2026. That implies a pathology Ebit margin of around 2%, down 30 bps on a year earlier. \"The outlook for growth in the pathology sector remains challenging--we continue to flag a decrease in FY 2026 net pathology funding of up to A$90 million,\" Jefferies says. \"Healius is not immune to this.\" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7509","HLS.AU","BK7501","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635273431","title":"BUZZ-Australia's Healius at record low on inadequate funding, budget pressure woes","url":"https://stock-news.laohu8.com/highlight/detail?id=2635273431","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635273431?lang=en_us&edition=fundamental","pubTime":"2026-05-13 11:28","pubTimestamp":1778642893,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Healius at record low on inadequate funding, budget pressure woes** Shares of Healius HLS.AX fall as much as 23.2% to a record low of A$0.373** Stock on track to log its worst session since late-November, 2023, if losses hold ** The healthcare company says inadequate funding resulted in cutting staff, closing collection centres and regional laboratories** Adds this year's federal budget will put additional pressure on a sector, which is a critical part of Australia's primary healthcare system** Expects FY26 underlying EBIT between A$30 million and A$35 million , higher than the A$17.1 million posted last year** About 16.3 million shares change hands, 4.5 times the 30-day avg ** Down 57.7% YTD, including the session's moves  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nL6N41Q07N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HLS.AU","BK7501","BK7509","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635220610","title":"Healius Issues Fiscal Year 2026 Guidance Amid Pathology Pressures; Explores Sale of Agilex Biolabs; Shares Drop 21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635220610","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635220610?lang=en_us&edition=fundamental","pubTime":"2026-05-13 10:09","pubTimestamp":1778638166,"startTime":"0","endTime":"0","summary":"Healius (ASX:HLS) said its pathology volumes grew 1.2% and revenue 3.5% in the fiscal first half, but volumes declined by 0.4% and revenue growth came in at a slower 2.4% for the 10 months to April, a","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HLS.AU","BK7501","BK7124","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635227962","title":"Healius Hits All-Time Stock Low After Profit Warning -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2635227962","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635227962?lang=en_us&edition=fundamental","pubTime":"2026-05-13 09:38","pubTimestamp":1778636280,"startTime":"0","endTime":"0","summary":"0138 GMT - Healius's share price drops 22% to an all-time low of A$0.38 after the Australian healthcare company warned on profits. Healius now expects underlying Ebitda of A$259 million-A$264 million in FY 2026. That's well below RBC's A$277 million forecast ahead of today's update. Analyst Craig Wong-Pan says the update implies Healius's pathology volumes deteriorated from 1.2% growth in 1H to a 2.8% decline in the four months through April, while pathology revenue growth fell to 0.7% in 2H so far, from 3.5% in 1H. \"We believe Healius has lost share in the 2H period given Medicare pathology volume and benefits paid growth for the three months to March were 1.9% and 1.6% respectively,\" RBC says. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7124","HLS.AU","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115684614","title":"Stock Track | Healius Ltd Plummets 10.31% Intraday Amid Funding Shortfall, Staff Cuts and Strategic Asset Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1115684614","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115684614?lang=en_us&edition=fundamental","pubTime":"2026-05-13 08:02","pubTimestamp":1778630564,"startTime":"0","endTime":"0","summary":"Healius Ltd's stock price plummeted 10.31% during intraday trading on Wednesday, marking a significant decline for the healthcare company.The sharp drop follows the company's announcement of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["HLS.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}]}}